Fig. 2.

Serial changes in immune cell populations according to Len-dex therapy. The frequency of each cell population at the time of Len-dex initiation (baseline, n = 85) and after completion of 1st, 2nd, and 3rd cycles of administration (n = 64, 59, and 45, respectively) was analyzed. CD3⁺, CD4⁺, CD8⁺ T cells, natural killer (NK) cells (CD16⁺CD56⁺), NKT-like cells (CD3⁺CD56⁺), and MDSCs (G-MDSC and M-MDSC) showed different changes. Data are presented as mean ± SEM and t tests were used to compare the continuous variables (baseline vs. each time point). *P < 0.05; **P < 0.01